Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v15-FR Version v2-FR
Language French French
Date Updated 2023-03-27 2023-02-09
Drug Identification Number 00786543 00786543
Brand name DILAUDID DILAUDID
Common or Proper name Hydromorphone hydrochloride Hydromorphone hydrochloride
Company Name PURDUE PHARMA PURDUE PHARMA
Ingredients HYDROMORPHONE HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE
Strength(s) 8MG 8MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code N02AA N02AA
ATC description OPIOIDS OPIOIDS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2023-02-09 2023-02-09
Actual start date 2023-02-09 2023-02-09
Estimated end date 2023-03-24 2023-03-31
Actual end date 2023-03-24
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments